125 related articles for article (PubMed ID: 30883291)
1. Catecholamine Modulation of Evidence Accumulation during Perceptual Decision Formation: A Randomized Trial.
Loughnane GM; Brosnan MB; Barnes JJM; Dean A; Nandam SL; O'Connell RG; Bellgrove MA
J Cogn Neurosci; 2019 Jul; 31(7):1044-1053. PubMed ID: 30883291
[TBL] [Abstract][Full Text] [Related]
2. Monoaminergic modulation of behavioural and electrophysiological indices of error processing.
Barnes JJ; O'Connell RG; Nandam LS; Dean AJ; Bellgrove MA
Psychopharmacology (Berl); 2014 Jan; 231(2):379-92. PubMed ID: 23995299
[TBL] [Abstract][Full Text] [Related]
3. Amplification and Suppression of Distinct Brainwide Activity Patterns by Catecholamines.
van den Brink RL; Nieuwenhuis S; Donner TH
J Neurosci; 2018 Aug; 38(34):7476-7491. PubMed ID: 30037827
[TBL] [Abstract][Full Text] [Related]
4. Dopamine Modulates the Efficiency of Sensory Evidence Accumulation During Perceptual Decision Making.
Beste C; Adelhöfer N; Gohil K; Passow S; Roessner V; Li SC
Int J Neuropsychopharmacol; 2018 Jul; 21(7):649-655. PubMed ID: 29618012
[TBL] [Abstract][Full Text] [Related]
5. Methylphenidate but not atomoxetine or citalopram modulates inhibitory control and response time variability.
Nandam LS; Hester R; Wagner J; Cummins TD; Garner K; Dean AJ; Kim BN; Nathan PJ; Mattingley JB; Bellgrove MA
Biol Psychiatry; 2011 May; 69(9):902-4. PubMed ID: 21193172
[TBL] [Abstract][Full Text] [Related]
6. Catecholaminergic neuromodulation and selective attention jointly shape perceptual decision-making.
Nuiten SA; de Gee JW; Zantvoord JB; Fahrenfort JJ; van Gaal S
Elife; 2023 Dec; 12():. PubMed ID: 38038722
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological Manipulations of Physiological Arousal and Sleep-Like Slow Waves Modulate Sustained Attention.
Pinggal E; Dockree PM; O'Connell RG; Bellgrove MA; Andrillon T
J Neurosci; 2022 Oct; 42(43):8113-8124. PubMed ID: 36109167
[TBL] [Abstract][Full Text] [Related]
8. Selective effects of serotonin on choices to gather more information.
Livermore JJ; Holmes CL; Cutler J; Levstek M; Moga G; Brittain JR; Campbell-Meiklejohn D
J Psychopharmacol; 2021 Jun; 35(6):631-640. PubMed ID: 33601931
[TBL] [Abstract][Full Text] [Related]
9. Catecholaminergic Modulation of Semantic Processing in Sentence Comprehension.
Tan Y; Hagoort P
Cereb Cortex; 2020 Nov; 30(12):6426-6443. PubMed ID: 32776103
[TBL] [Abstract][Full Text] [Related]
10. Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: a randomized cross-over study.
Windischberger C; Lanzenberger R; Holik A; Spindelegger C; Stein P; Moser U; Gerstl F; Fink M; Moser E; Kasper S
Neuroimage; 2010 Jan; 49(2):1161-70. PubMed ID: 19833214
[TBL] [Abstract][Full Text] [Related]
11. The system-neurophysiological basis for how methylphenidate modulates perceptual-attentional conflicts during auditory processing.
Adelhöfer N; Gohil K; Passow S; Teufert B; Roessner V; Li SC; Beste C
Hum Brain Mapp; 2018 Dec; 39(12):5050-5061. PubMed ID: 30133058
[TBL] [Abstract][Full Text] [Related]
12. Task experience eliminates catecholaminergic effects on inhibitory control - A randomized, double-blind cross-over neurophysiological study.
Mückschel M; Roessner V; Beste C
Eur Neuropsychopharmacol; 2020 Jun; 35():89-99. PubMed ID: 32402650
[TBL] [Abstract][Full Text] [Related]
13. Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures.
Ye Z; Rae CL; Nombela C; Ham T; Rittman T; Jones PS; Rodríguez PV; Coyle-Gilchrist I; Regenthal R; Altena E; Housden CR; Maxwell H; Sahakian BJ; Barker RA; Robbins TW; Rowe JB
Hum Brain Mapp; 2016 Mar; 37(3):1026-37. PubMed ID: 26757216
[TBL] [Abstract][Full Text] [Related]
14. Anxiety reduction on atomoxetine and methylphenidate medication in children with ADHD.
Snircova E; Marcincakova-Husarova V; Hrtanek I; Kulhan T; Ondrejka I; Nosalova G
Pediatr Int; 2016 Jun; 58(6):476-81. PubMed ID: 26579704
[TBL] [Abstract][Full Text] [Related]
15. Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice.
Koda K; Ago Y; Cong Y; Kita Y; Takuma K; Matsuda T
J Neurochem; 2010 Jul; 114(1):259-70. PubMed ID: 20403082
[TBL] [Abstract][Full Text] [Related]
16. Atomoxetine increases salivary cortisol in healthy volunteers.
Chamberlain SR; Müller U; Cleary S; Robbins TW; Sahakian BJ
J Psychopharmacol; 2007 Jul; 21(5):545-9. PubMed ID: 17446206
[TBL] [Abstract][Full Text] [Related]
17. Catecholaminergic modulation of trust decisions.
Rățală CE; Fallon SJ; van der Schaaf ME; Ter Huurne N; Cools R; Sanfey AG
Psychopharmacology (Berl); 2019 Jun; 236(6):1807-1816. PubMed ID: 30706097
[TBL] [Abstract][Full Text] [Related]
18. Distinct neural markers of evidence accumulation index metacognitive processing before and after simple visual decisions.
Stone C; Mattingley JB; Bode S; Rangelov D
Cereb Cortex; 2024 May; 34(5):. PubMed ID: 38706138
[TBL] [Abstract][Full Text] [Related]
19. Shared and drug-specific effects of atomoxetine and methylphenidate on inhibitory brain dysfunction in medication-naive ADHD boys.
Cubillo A; Smith AB; Barrett N; Giampietro V; Brammer MJ; Simmons A; Rubia K
Cereb Cortex; 2014 Jan; 24(1):174-85. PubMed ID: 23048018
[TBL] [Abstract][Full Text] [Related]
20. Blocking serotonin but not dopamine reuptake alters neural processing during perceptual decision making.
Costa VD; Kakalios LC; Averbeck BB
Behav Neurosci; 2016 Oct; 130(5):461-8. PubMed ID: 27513807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
